Legal & General Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-381,430
| Closed | -$20M | – | 3530 |
|
|
2020
Q3 | $20M | Buy |
381,430
+7,854
| +2% | +$325K | 0.01% | 789 |
|
|
2020
Q2 | $12.4M | Buy |
373,576
+37,489
| +11% | +$1.19M | 0.01% | 911 |
|
|
2020
Q1 | $9.14M | Buy |
336,087
+14,146
| +4% | +$394K | 0.01% | 937 |
|
|
2019
Q4 | $6.35M | Buy |
321,941
+53,848
| +20% | +$861K | ﹤0.01% | 1246 |
|
|
2019
Q3 | $3.47M | Buy |
268,093
+4,355
| +2% | +$52.6K | ﹤0.01% | 1470 |
|
|
2019
Q2 | $3.28M | Sell |
263,738
-438
| -0.2% | -$5.82K | ﹤0.01% | 1480 |
|
|
2019
Q1 | $3.84M | Buy |
264,176
+44,869
| +20% | +$573K | ﹤0.01% | 1360 |
|
|
2018
Q4 | $2.42M | Buy |
219,307
+36,202
| +20% | +$504K | ﹤0.01% | 1491 |
|
|
2018
Q3 | $4.72M | Buy |
183,105
+13,239
| +8% | +$358K | ﹤0.01% | 1211 |
|
|
2018
Q2 | $3.44M | Buy |
169,866
+10,593
| +7% | +$227K | ﹤0.01% | 1352 |
|
|
2018
Q1 | $2.87M | Buy |
159,273
+3,438
| +2% | +$57.3K | ﹤0.01% | 1416 |
|
|
2017
Q4 | $2.17M | Buy |
155,835
+1,775
| +1% | +$24K | ﹤0.01% | 1579 |
|
|
2017
Q3 | $2.85M | Buy |
154,060
+27,173
| +21% | +$454K | ﹤0.01% | 1381 |
|
|
2017
Q2 | $2.15M | Buy |
126,887
+14,424
| +13% | +$220K | ﹤0.01% | 1488 |
|
|
2017
Q1 | $1.5M | Buy |
112,463
+2,603
| +2% | +$40.8K | ﹤0.01% | 1633 |
|
|
2016
Q4 | $1.65M | Buy |
109,860
+53,786
| +96% | +$710K | ﹤0.01% | 1518 |
|
|
2016
Q3 | $653K | Buy |
56,074
+42,841
| +324% | +$504K | ﹤0.01% | 1578 |
|
|
2016
Q2 | $141K | Hold |
13,233
| – | – | ﹤0.01% | 1919 |
|
|
2016
Q1 | $121K | Sell |
13,233
-629
| -5% | -$6.77K | ﹤0.01% | 1947 |
|
|
2015
Q4 | $204K | Hold |
13,862
| – | – | ﹤0.01% | 1737 |
|
|
2015
Q3 | $227K | Buy |
13,862
+2,299
| +20% | +$47.1K | ﹤0.01% | 1643 |
|
|
2015
Q2 | $265K | Buy |
11,563
+2,290
| +25% | +$45.6K | ﹤0.01% | 1606 |
|
|
2015
Q1 | $143K | Buy |
9,273
+674
| +8% | +$8.76K | ﹤0.01% | 1831 |
|
|
2014
Q4 | $104K | Sell |
8,599
-626
| -7% | -$7.15K | ﹤0.01% | 1943 |
|
|
2014
Q3 | $101K | Buy |
+9,225
| New | +$105K | ﹤0.01% | 1882 |
|
Legal & General Group's MNTA Position: Q4 2020 in Review
Legal & General Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 381,430 shares — an estimated $20M sold.
Legal & General Group first reported a position in MNTA in Q3 2014 and held it in 25 quarters. The position peaked at $20M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Legal & General Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Legal & General Group sold 381,430 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $20M.
- Legal & General Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2014 and held it in 25 quarters.
- Legal & General Group's Momenta Pharmaceuticals, Inc. position peaked at $20M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Legal & General Group's 13F filing for Q4 2020, filed 12 Feb 2021.